EUVIMEDEUVIMED entdecken
Crossref

Adjuvant ultra-hypofractionated radiotherapy up-front to third-generation adjuvant chemotherapy for breast cancer: A retrospective propensity score matched control group study

G. Lazzari, I. Benevento, B. D'Andrea, A. Bianculli, R. Tucciariello, V. Metallo, A. Montagna

European Journal of Cancer · 2026-03 · 237 · 116420

DOI: 10.1016/j.ejca.2026.116420 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Cancer, 2026-03. Verfasst von G. Lazzari und 6 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Lazzari, G., Benevento, I., D'Andrea, B., Bianculli, A., Tucciariello, R., Metallo, V., & Montagna, A. (2026). Adjuvant ultra-hypofractionated radiotherapy up-front to third-generation adjuvant chemotherapy for breast cancer: A retrospective propensity score matched control group study. European Journal of Cancer, 237, 116420. https://doi.org/10.1016/j.ejca.2026.116420

Vancouver

Lazzari G, Benevento I, D'Andrea B, Bianculli A, Tucciariello R, Metallo V, et al. Adjuvant ultra-hypofractionated radiotherapy up-front to third-generation adjuvant chemotherapy for breast cancer: A retrospective propensity score matched control group study. European Journal of Cancer. 2026;237:116420. doi:10.1016/j.ejca.2026.116420

BibTeX
@article{Lazzari2026,
  author = {Lazzari, G. and Benevento, I. and D'Andrea, B. and Bianculli, A. and Tucciariello, R. and Metallo, V. and Montagna, A.},
  title = {Adjuvant ultra-hypofractionated radiotherapy up-front to third-generation adjuvant chemotherapy for breast cancer: A retrospective propensity score matched control group study},
  journal = {European Journal of Cancer},
  year = {2026},
  volume = {237},
  pages = {116420},
  doi = {10.1016/j.ejca.2026.116420}
}
Kostenlos starten →